APA (7th ed.) Citation

E, H., K, H., GSP, M., R, P., PK, D., MD, A. S., . . . KR, J. (2025). Advancements of anticancer agents by targeting the Hippo signalling pathway: Biological activity, selectivity, docking analysis, and structure-activity relationship. Molecular diversity, 29(3), 2829. https://doi.org/10.1007/s11030-024-11009-1

Chicago Style (17th ed.) Citation

E, Haripriya, et al. "Advancements of Anticancer Agents by Targeting the Hippo Signalling Pathway: Biological Activity, Selectivity, Docking Analysis, and Structure-activity Relationship." Molecular Diversity 29, no. 3 (2025): 2829. https://doi.org/10.1007/s11030-024-11009-1.

MLA (9th ed.) Citation

E, Haripriya, et al. "Advancements of Anticancer Agents by Targeting the Hippo Signalling Pathway: Biological Activity, Selectivity, Docking Analysis, and Structure-activity Relationship." Molecular Diversity, vol. 29, no. 3, 2025, p. 2829, https://doi.org/10.1007/s11030-024-11009-1.